封面
市场调查报告书
商品编码
1485297

语音假体设备市场规模- 按产品(留置和非留置语音假体)、阀门类型(Provox 阀门、Blom-Singer 阀门、Groningen 阀门)、最终用途(医院、门诊手术中心)- 全球预测,2024 年- 2032 年

Voice Prosthesis Devices Market Size - By Product (Indwelling & Non-Indwelling Voice Prosthesis), Valve Type (Provox Valve, Blom-Singer Valve, Groningen Valve), End-use (Hospitals, Ambulatory Surgical Centers) - Global Forecast, 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3个工作天内

价格
简介目录

由于旨在恢復语音能力的创新设备的不断发展,全球语音义肢设备市场规模在 2024 年至 2032 年间将实现 6.7% 的复合年增长率。这些进步为因喉癌或声带麻痹等疾病而面临发声挑战的个人提供了有希望的解决方案。例如,2022 年 4 月,澳洲新创公司 Laronix 正在开发一种仿生设备,采用人工智慧驱动的语音克隆技术来恢復喉切除患者的声音。这家总部位于昆士兰的公司率先开发了由人工智慧支援的仿生声音,旨在为经历过声带切除的人提供言语便利,同时恢復他们独特而独特的声音。

从气管食道穿刺 (TEP) 阀到电喉设备,市场上正在见证旨在提高说话能力的新技术的激增。随着这些设备变得更加复杂和易于使用,它们不仅提高了言语障碍人士的生活质量,而且推动了语音义肢设备市场的成长。对改善沟通结果的日益关注推动了持续的研究和创新,塑造了言语復健技术的格局。

整个语音义肢设备产业根据产品、阀门类型、最终用途和地区进行分类。

从 2024 年到 2032 年,非留置发声器市场将经历重大发展。与留置义肢不同,非留置装置不需要频繁更换或专业干预,方便且具成本效益。此外,材料和设计的进步提高了耐用性和舒适度,进一步推动了市场成长。随着对高效且患者友善解决方案的需求持续增长,非留置发声设备的市场有望大幅扩张。

从2024 年到2032 年,Blom Singer 阀门领域的发声义肢设备市场份额将实现显着的复合年增长率。 这种创新设备为接受过喉切除术的个人提供了可靠的解决方案,使他们能够恢復言语能力。 Blom-Singer 阀门因其耐用性、易用性和促进声音产生的有效性而脱颖而出。其独特的设计和先进的功能使其成为患者和医疗保健专业人员的首选。随着对高效能、高品质发声器的需求持续成长,Blom-Singer 阀门仍然是市场扩张的关键贡献者。

欧洲发声义肢设备市场从 2024 年到 2032 年将呈现出值得称讚的复合年增长率。该地区的人口老化和喉癌等疾病盛行率的增加加剧了这一需求。此外,医疗技术和报销政策的进步进一步促进了市场成长。欧洲患者和医疗保健专业人员优先考虑提供耐用性、有效性和改善生活品质的设备。因此,在医疗保健行业不断变化的需求的推动下,欧洲的语音义肢设备市场正在持续扩张。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 喉癌盛行率增加
      • 日益关注以病人为中心的护理
      • 发声义肢设备的技术进步
    • 产业陷阱与挑战
      • 与发声义肢设备和相关程序相关的高成本
  • 成长潜力分析
  • 监管环境
  • 2023 年定价分析
  • 波特的分析
  • PESTEL分析
  • 报销场景
  • 未来市场趋势
  • 缺口分析

第 4 章:竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章:市场估计与预测:按产品分类,2018 年 - 2032 年

  • 主要趋势
  • 留置发声假体
  • 非留置发声假体

第 6 章:市场估计与预测:按阀门类型,2018 - 2032 年

  • 主要趋势
  • 普罗沃克斯阀门
  • 布洛姆辛格阀
  • 格罗宁根阀门

第 7 章:市场估计与预测:按最终用途,2018 - 2032 年

  • 主要趋势
  • 医院
  • 门诊手术中心
  • 其他最终用户

第 8 章:市场估计与预测:按地区划分,2018 年 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 9 章:公司简介

  • Andreas Fahl Medizintechnik-Vertrieb GmbH
  • Atos Medical
  • HEIMOMED Heinze GmbH & Co. KG
  • Hood Laboratories
  • ICU Medical, Inc.
  • InHealth Technologies
  • Innaumation Medical Devices Private Limited
  • Luminaud, Inc.
  • Servona GmbH
  • Teleflex Incorporated
简介目录
Product Code: 8495

Global Voice Prosthesis Devices Market Size will witness 6.7% CAGR between 2024 and 2032 due to the increasing development of innovative devices aimed at restoring speech capabilities. These advancements offer promising solutions for individuals facing challenges in vocalization due to conditions such as laryngeal cancer or vocal cord paralysis. For instance, in April 2022, Laronix, an Australian start-up, was in the process of creating a bionic device employing AI-driven voice-cloning technology to restore the voices of laryngectomy patients. This Queensland-based company was pioneering the development of an AI-supported bionic voice, aiming to facilitate speech for individuals who have undergone voice box removal while restoring their unique and distinctive voices.

From tracheoesophageal puncture (TEP) valves to electrolarynx devices, the market is witnessing a proliferation of new technologies designed to improve speaking abilities. As these devices become more sophisticated and accessible, they not only enhance the quality of life for individuals with speech impairments but also drive growth in the Voice Prosthesis Devices market. The rising focus on improving communication outcomes fuels ongoing research and innovation, shaping the landscape of speech rehabilitation technologies.

The overall Voice Prosthesis Devices Industry is classified based on the product, valve type, end-use, and region.

The non-indwelling voice prosthesis segment will experience significant progression from 2024 to 2032. These devices offer a minimally invasive solution for individuals who have undergone laryngectomy, allowing them to regain their speech abilities. Unlike indwelling prostheses, non-indwelling devices do not require frequent replacement or professional intervention, offering convenience and cost-effectiveness. Moreover, advancements in materials and design have led to improved durability and comfort, further driving market growth. As the demand for efficient and patient-friendly solutions continues to rise, the market for non-indwelling voice prosthesis devices is poised for significant expansion.

The voice prosthesis devices market share from the Blom Singer valve segment will register a notable CAGR from 2024 to 2032. This innovative device offers a reliable solution for individuals who have undergone laryngectomy, enabling them to restore their speech abilities. The Blom-Singer Valve stands out for its durability, ease of use, and effectiveness in facilitating voice production. Its unique design and advanced features make it a preferred choice among patients and healthcare professionals alike. As the demand for efficient and high-quality voice prostheses continues to grow, the Blom-Singer Valve remains a key contributor to the market expansion.

Europe voice prosthesis devices market will showcase a commendable CAGR from 2024 to 2032. With a focus on healthcare innovation and patient-centered care, European countries are witnessing a growing demand for voice prostheses. The region's aging population and increasing prevalence of conditions such as laryngeal cancer contribute to this demand. Additionally, advancements in medical technology and reimbursement policies further boost market growth. European patients and healthcare professionals prioritize devices that offer durability, effectiveness, and improved quality of life. As a result, the Voice Prosthesis Devices market in Europe is experiencing sustained expansion, driven by the evolving needs of the healthcare sector.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data sources
    • 1.5.1 Primary
    • 1.5.2 Secondary
      • 1.5.2.1 Paid sources
      • 1.5.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of laryngeal cancer
      • 3.2.1.2 Rising focus on patient-centric care
      • 3.2.1.3 Technological advancements in voice prosthesis devices
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost associated with voice prosthesis devices and related procedures
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Pricing analysis, 2023
  • 3.6 Porter's analysis
    • 3.6.1 Supplier power
    • 3.6.2 Buyer power
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
    • 3.6.5 Industry rivalry
  • 3.7 PESTEL analysis
  • 3.8 Reimbursement scenario
  • 3.9 Future market trends
  • 3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Indwelling voice prosthesis
  • 5.3 Non-indwelling voice prosthesis

Chapter 6 Market Estimates and Forecast, By Valve Type, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Provox valve
  • 6.3 Blom-singer valve
  • 6.4 Groningen valve

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers
  • 7.4 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Andreas Fahl Medizintechnik-Vertrieb GmbH
  • 9.2 Atos Medical
  • 9.3 HEIMOMED Heinze GmbH & Co. KG
  • 9.4 Hood Laboratories
  • 9.5 ICU Medical, Inc.
  • 9.6 InHealth Technologies
  • 9.7 Innaumation Medical Devices Private Limited
  • 9.8 Luminaud, Inc.
  • 9.9 Servona GmbH
  • 9.10 Teleflex Incorporated